Does MetLife (NYSE:MET) Look Attractive Now? Credit Suisse Initiates Coverage

April 26, 2018 - By Dolores Ford

MetLife, Inc. (NYSE:MET) Logo

Investors sentiment increased to 1.02 in Q4 2017. Its up 0.13, from 0.89 in 2017Q3. It improved, as 45 investors sold MetLife, Inc. shares while 330 reduced holdings. 93 funds opened positions while 290 raised stakes. 782.94 million shares or 0.24% less from 784.85 million shares in 2017Q3 were reported.

United Kingdom-based Pictet Asset Management Ltd has invested 0.08% in MetLife, Inc. (NYSE:MET). Moreover, Birmingham Capital Mgmt Al has 0.26% invested in MetLife, Inc. (NYSE:MET). Everence has invested 0.27% in MetLife, Inc. (NYSE:MET). 22,845 are owned by Ameritas Inv Partners. Moreover, Paloma Prns Mngmt Company has 0.17% invested in MetLife, Inc. (NYSE:MET) for 252,043 shares. Clearbridge Lc has 0.91% invested in MetLife, Inc. (NYSE:MET). Signaturefd Ltd Limited Liability Company reported 4,098 shares or 0.02% of all its holdings. Silvercrest Asset Mgmt Limited Liability Company reported 0.02% in MetLife, Inc. (NYSE:MET). Pennsylvania has 0.07% invested in MetLife, Inc. (NYSE:MET) for 31,637 shares. First Republic Inv Inc has 0.03% invested in MetLife, Inc. (NYSE:MET). Beacon Capital Mngmt holds 0% in MetLife, Inc. (NYSE:MET) or 18 shares. The France-based Axa has invested 0.03% in MetLife, Inc. (NYSE:MET). Crawford Counsel invested in 1.05 million shares or 1.65% of the stock. Vantage Investment Advisors Limited Co accumulated 0.01% or 777 shares. Pekin Singer Strauss Asset Mngmt Il invested 0.09% in MetLife, Inc. (NYSE:MET).

Why Has Credit Suisse Given MetLife (NYSE:MET) a $67 Price Target

Credit Suisse analyst has begun coverage with a Outperform rating on MetLife (NYSE:MET) today and set a price target of $67. The company’s shares opened today at 47.91.

Investors sentiment increased to 1.02 in Q4 2017. Its up 0.13, from 0.89 in 2017Q3. It improved, as 45 investors sold MetLife, Inc. shares while 330 reduced holdings. 93 funds opened positions while 290 raised stakes. 782.94 million shares or 0.24% less from 784.85 million shares in 2017Q3 were reported.

United Kingdom-based Pictet Asset Management Ltd has invested 0.08% in MetLife, Inc. (NYSE:MET). Moreover, Birmingham Capital Mgmt Al has 0.26% invested in MetLife, Inc. (NYSE:MET). Everence has invested 0.27% in MetLife, Inc. (NYSE:MET). 22,845 are owned by Ameritas Inv Partners. Moreover, Paloma Prns Mngmt Company has 0.17% invested in MetLife, Inc. (NYSE:MET) for 252,043 shares. Clearbridge Lc has 0.91% invested in MetLife, Inc. (NYSE:MET). Signaturefd Ltd Limited Liability Company reported 4,098 shares or 0.02% of all its holdings. Silvercrest Asset Mgmt Limited Liability Company reported 0.02% in MetLife, Inc. (NYSE:MET). Pennsylvania has 0.07% invested in MetLife, Inc. (NYSE:MET) for 31,637 shares. First Republic Inv Inc has 0.03% invested in MetLife, Inc. (NYSE:MET). Beacon Capital Mngmt holds 0% in MetLife, Inc. (NYSE:MET) or 18 shares. The France-based Axa has invested 0.03% in MetLife, Inc. (NYSE:MET). Crawford Counsel invested in 1.05 million shares or 1.65% of the stock. Vantage Investment Advisors Limited Co accumulated 0.01% or 777 shares. Pekin Singer Strauss Asset Mngmt Il invested 0.09% in MetLife, Inc. (NYSE:MET).

MetLife, Inc. (NYSE:MET) Ratings Coverage

Among 10 analysts covering Metlife (NYSE:MET), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Metlife has $67 highest and $4700 lowest target. $56.22’s average target is 17.35% above currents $47.91 stock price. Metlife had 17 analyst reports since November 3, 2017 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Wednesday, February 14 with “Equal-Weight”. Sandler O’Neill maintained MetLife, Inc. (NYSE:MET) on Thursday, April 5 with “Hold” rating. The stock has “Hold” rating by Sandler O’Neill on Friday, November 10. As per Thursday, April 5, the company rating was maintained by Morgan Stanley. Morgan Stanley maintained it with “Equal-Weight” rating and $57 target in Monday, November 13 report. The stock of MetLife, Inc. (NYSE:MET) earned “Hold” rating by Sandler O’Neill on Thursday, February 15. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) on Friday, November 3 with “Buy” rating. The stock of MetLife, Inc. (NYSE:MET) earned “Buy” rating by Keefe Bruyette & Woods on Wednesday, April 11. The company was upgraded on Monday, March 26 by Atlantic Securities. The firm has “Buy” rating by Keefe Bruyette & Woods given on Thursday, December 21.

The stock increased 0.17% or $0.08 during the last trading session, reaching $47.91. About 371,692 shares traded. MetLife, Inc. (NYSE:MET) has declined 1.24% since April 26, 2017 and is downtrending. It has underperformed by 12.79% the S&P500.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on May, 2 after the close. They expect $1.17 earnings per share, down 19.86 % or $0.29 from last year’s $1.46 per share. MET’s profit will be $1.21B for 10.24 P/E if the $1.17 EPS becomes a reality. After $1.11 actual earnings per share reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 5.41 % EPS growth.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. The company has market cap of $49.67 billion. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial. It has a 13.25 P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.

MetLife, Inc. (NYSE:MET) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.